The role of coronary artery calcification score in lung cancer patients
Valerio Nardone(University of Campania "Luigi Vanvitelli"), Salvatore Cappabianca(University of Campania "Luigi Vanvitelli"), Roberta Grassi(University of Campania "Luigi Vanvitelli"), Carminia Maria Della Corte(University of Campania "Luigi Vanvitelli"), Teresa Di Pietro(University of Campania "Luigi Vanvitelli"), Alfonso Reginelli(University of Campania "Luigi Vanvitelli"), Morena Fasano, Fortunato Ciardiello(University of Campania "Luigi Vanvitelli"), Giovanni Vicidomini(University of Campania "Luigi Vanvitelli"), Floriana Morgillo(University of Campania "Luigi Vanvitelli"), Giuseppina De Marco(Azienda Ospedaliero-Universitaria di Modena), Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia)
Cited by 3
Related Papers
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|The Lancet|2016|4.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k